Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Murphy

Showing results (101-110 of 110) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 110 results.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|August 1, 1997
A comparative trial of zidovudine administered every four versus every twelve hours for the treatment of advanced HIV diseaseD H Shepp, C Ramirez-Ronda, L Dall, et al.
JAMA|July 13, 2000
Immunologic and virologic effects of subcutaneous interleukin 2 in combination with antiretroviral therapy: A randomized controlled trialR T Davey, R L Murphy, F M Graziano, et al.
HIV Clinical Trials|October 9, 2001
Low-dose daily subcutaneous interleukin-2 in combination with highly active antiretroviral therapy in HIV+ patients: a randomized controlled trialJ P Lalezari, J A Beal, P J Ruane, et al.
Epidemiology and Infection|January 16, 2018
Clinical characteristics of non-tuberculous mycobacterial pulmonary infections in Bamako, MaliB Kone, Y S Sarro, M Maiga, et al.
BMC Infectious Diseases|November 30, 2016
Tuberculosis drug resistance in Bamako, Mali, from 2006 to 2014B Diarra, D Goita, S Tounkara, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 23, 2017
Performance of microscopic observation drug susceptibility for the rapid diagnosis of tuberculosis and detection of drug resistance in Bamako, MaliM Sanogo, B Kone, B Diarra, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 11, 2020
Fluorescein diacetate and rapid molecular testing for the early identification of rifampicin resistance in MaliB Diarra, T Decroo, A Somboro, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|December 3, 2019
Diabetes Mellitus among new tuberculosis patients in Bamako, MaliB Diarra, M Tolofoudie, Y S Sarro, et al.
Lancet (London, England)|April 20, 2004
Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN StudyF van Leth, P Phanuphak, K Ruxrungtham, et al.
Annals of Internal Medicine|March 1, 1993
Alternating and intermittent regimens of zidovudine and dideoxycytidine in patients with AIDS or AIDS-related complexG Skowron, S A Bozzette, L Lim, et al.
Pageof 11

Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|August 1, 1997
A comparative trial of zidovudine administered every four versus every twelve hours for the treatment of advanced HIV diseaseD H Shepp, C Ramirez-Ronda, L Dall, et al.
JAMA|July 13, 2000
Immunologic and virologic effects of subcutaneous interleukin 2 in combination with antiretroviral therapy: A randomized controlled trialR T Davey, R L Murphy, F M Graziano, et al.
HIV Clinical Trials|October 9, 2001
Low-dose daily subcutaneous interleukin-2 in combination with highly active antiretroviral therapy in HIV+ patients: a randomized controlled trialJ P Lalezari, J A Beal, P J Ruane, et al.
Epidemiology and Infection|January 16, 2018
Clinical characteristics of non-tuberculous mycobacterial pulmonary infections in Bamako, MaliB Kone, Y S Sarro, M Maiga, et al.
BMC Infectious Diseases|November 30, 2016
Tuberculosis drug resistance in Bamako, Mali, from 2006 to 2014B Diarra, D Goita, S Tounkara, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 23, 2017
Performance of microscopic observation drug susceptibility for the rapid diagnosis of tuberculosis and detection of drug resistance in Bamako, MaliM Sanogo, B Kone, B Diarra, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 11, 2020
Fluorescein diacetate and rapid molecular testing for the early identification of rifampicin resistance in MaliB Diarra, T Decroo, A Somboro, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|December 3, 2019
Diabetes Mellitus among new tuberculosis patients in Bamako, MaliB Diarra, M Tolofoudie, Y S Sarro, et al.
Lancet (London, England)|April 20, 2004
Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN StudyF van Leth, P Phanuphak, K Ruxrungtham, et al.
Annals of Internal Medicine|March 1, 1993
Alternating and intermittent regimens of zidovudine and dideoxycytidine in patients with AIDS or AIDS-related complexG Skowron, S A Bozzette, L Lim, et al.
Pageof 11